| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |